Argitalpenak (21) ROCIO FUENTE PEREZ argitalpenak Ostatu hartutako ikerketa-datuak ikusi.

2024

  1. A Computational Approach to Individual Cell-Based Decision Algorithms Involved in Bone Remodeling

    Mathematics, Vol. 12, Núm. 3

  2. A novel mouse model for familial hypocalciuric hypercalcemia (FHH1) reveals PTH-dependent and independent CaSR defects

    Pflugers Archiv European Journal of Physiology, Vol. 476, Núm. 5, pp. 833-845

2023

  1. Blocking FGF23 signaling improves the growth plate of mice with X-linked hypophosphatemia

    The Journal of endocrinology, Vol. 259, Núm. 1

2022

  1. A FoxA2+ long-term stem cell population is necessary for growth plate cartilage regeneration after injury

    Nature Communications, Vol. 13, Núm. 1

  2. Cellular and Molecular Alterations Underlying Abnormal Bone Growth in X-Linked Hypophosphatemia

    International Journal of Molecular Sciences, Vol. 23, Núm. 2

2021

  1. Modelos experimentales animales

    Nefrología pediátrica (Ediciones de la Universidad de Oviedo), pp. 1095-1102

  2. Systemic Jak1 activation causes extrarenal calcitriol production and skeletal alterations provoking stunted growth

    FASEB Journal, Vol. 35, Núm. 7

  3. The formation of the epiphyseal bone plate occurs via combined endochondral and intramembranous-like ossification

    International Journal of Molecular Sciences, Vol. 22, Núm. 2, pp. 1-16

2020

  1. A simple method based on confocal microscopy and thick sections recognizes seven subphases in growth plate chondrocytes

    Scientific Reports, Vol. 10, Núm. 1

  2. Innovative three-dimensional microscopic analysis of uremic growth plate discloses alterations in the process of chondrocyte hypertrophy: Effects of growth hormone treatment

    International Journal of Molecular Sciences, Vol. 21, Núm. 12, pp. 1-14

2019

  1. Correction to: X-linked hypophosphatemia and growth (Reviews in Endocrine and Metabolic Disorders, (2017), 18, 1, (107-115), 10.1007/s11154-017-9408-1)

    Reviews in Endocrine and Metabolic Disorders

  2. MAPK inhibition and growth hormone: a promising therapy in XLH

    FASEB Journal, Vol. 33, Núm. 7, pp. 8349-8362

  3. The SRC inhibitor dasatinib induces stem cell-like properties in head and neck cancer cells that are effectively counteracted by the mithralog EC-8042

    Journal of Clinical Medicine, Vol. 8, Núm. 8

2018

  1. Marked alterations in the structure, dynamics and maturation of growth plate likely explain growth retardation and bone deformities of young Hyp mice

    Bone, Vol. 116, pp. 187-195

2017

  1. Effects of growth hormone treatment on growth plate, bone, and mineral metabolism of young rats with uremia induced by adenine

    Pediatric Research, Vol. 82, Núm. 1, pp. 148-154

  2. Poor phenotype-genotype association in a large series of patients with Type III Bartter syndrome

    PLoS ONE, Vol. 12, Núm. 3

  3. X-linked hypophosphatemia and growth

    Reviews in Endocrine and Metabolic Disorders, Vol. 18, Núm. 1, pp. 107-115

2015

  1. Animal models of pediatric chronic kidney disease. Is adenine intake an appropriate model?

    Nefrologia

  2. Chronic kidney disease induced by adenine: A suitable model of growth retardation in uremia

    American Journal of Physiology - Renal Physiology, Vol. 309, Núm. 1, pp. F57-F62

2013

  1. Dent’s disease: Identification of seven new pathogenic mutations in the CLCN5 gene

    Journal of Pediatric Genetics, Vol. 2, Núm. 3, pp. 133-140